XIAP Mediates NOD Signaling Via Interaction with RIP2

Total Page:16

File Type:pdf, Size:1020Kb

XIAP Mediates NOD Signaling Via Interaction with RIP2 XIAP mediates NOD signaling via interaction with RIP2 Andreas Kriega,b, Ricardo G. Correaa, Jason B. Garrisona, Gae¨ lle Le Negratea,c, Kate Welsha, Ziwei Huanga, Wolfram T. Knoefelb, and John C. Reeda,1 aBurnham Institute for Medical Research, La Jolla, CA 92037; bDepartment of General, Visceral and Pediatric Surgery, University Hospital Duesseldorf, D-40225 Duesseldorf, Germany; and cInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Duessledorf, D40225 Duesseldorf, Germany Communicated by Erkki Ruoslahti, Burnham Institute for Medical Research at University of California, Santa Barbara, CA, July 6, 2009 (received for review June 11, 2009) NOD1 and NOD2 are members of the NOD-like receptor (NLR) protein signal transduction processes, which include activation of MAPKs family that are involved in sensing the presence of pathogens and are (23) and NF-␬B through interactions of TAB1/TAK1 with its BIR1 a component of the innate immune system. Upon activation by domain (25). specific bacterial peptides derived from peptidoglycans, NODs inter- Hints that IAP-family members might be involved in innate act via a CARD-CARD interaction with the receptor-interacting protein immunity have come from studies demonstrating that flies depleted kinase RIP2, an inducer of NF-␬B activation. In this report, we show by shRNA of Drosophila IAP-2 (DIAP2) fail to activate NF-␬Bin that NOD signaling is dependent on XIAP, a member of the inhibitor response to bacterial challenge with Escherichia coli and show of apoptosis protein (IAP) family. Cells deficient in XIAP exhibit a decreased survival rates when exposed to Enterobacter cloacae (26, marked reduction in NF-␬B activation induced by microbial NOD 27). Recently, studies of xiapϪ/Ϫ mice have provided evidence of ligands and by over-expression of NOD1 or NOD2. Moreover, we a contribution of XIAP to NF-␬B and JNK activation induced by show that XIAP interacts with RIP2 via its BIR2 domain, which could TLRs and NLRs during infection with Listeria monocytogenes, be disrupted by XIAP antagonists SMAC and SMAC-mimicking com- further supporting the hypothesis that IAPs may participate in pounds. Both NOD1 and NOD2 associated with XIAP in a RIP2- innate immune responses (28). Here we show that XIAP is required dependent manner, providing evidence that XIAP associates with the at least in certain types of epithelial cells for NF-␬B activation NOD signalosome. Taken together, our data suggest a role for XIAP induced by NOD1 and NOD2, and demonstrate that XIAP binds MEDICAL SCIENCES in regulating innate immune responses by interacting with NOD1 and RIP2 thereby associating with NOD1/NOD2 signaling complexes. NOD2 through interaction with RIP2. Results he NOD-like receptors (NLRs) constitute a family of innate XIAP Is Required for NOD Signaling. Epithelial cells of the intestinal immunity proteins involved in sensing the presence of intracel- track are a first line of defense against many microorganisms. We T took advantage of human tumor cell lines derived from colonic lular pathogens and stimulating host defense responses (2). Two of epithelium in which the XIAP gene had been ablated by homolo- these family members, NOD1 and NOD2, share structural and gous recombination to ask whether XIAP is required for cellular functional characteristics. Both, NOD1 and NOD2, contain C- responses to synthetic NOD1 or NOD2 ligands. Accordingly, terminal leucine-rich repeats (LRRs) thought to act as receptors for isogenic pairs of XIAPϩ/ϩ and XIAPϪ/Ϫ HCT116 and DLD-1 pathogen-derived molecules, a central nucleotide-binding oli- cells were stimulated for 24 h with NOD1 and NOD2 ligands, gomerization domain (NACHT) (3, 4), and N-terminal caspase L-Ala-␥-D-Glu-mDAP (DAP) and muramyl dipeptide (MDP), recruitment domains (CARDs) that associate with down-stream respectively, then Interleukin-8 (IL-8) production was measured signaling proteins (5, 6). NODs activation is stimulated by bacterial (Fig. 1A and B). Both DAP and MDP induced increases in IL-8 peptides derived from peptidoglycans, with diaminopimelic acid production in the wild-type HCT116 and DLD-1 cells, with MDP (DAP) stimulating NOD1 (7, 8), and muramyl dipeptide (MDP) more potent than DAP. In contrast, neither of these NOD ligands activating NOD2 (9, 10). Upon recognition of these ligands, oli- induced IL-8 production in cultures of XIAP-deficient HCT116 gomerization of the NACHT domains initiates the recruitment of and DLD1. Whereas XIAPϪ/Ϫ cells failed to respond to NOD interacting proteins, binding the serine/threonine protein kinase ligands, they remained responsive to TNF, which induced robust RIP2/CARDIAK/RICK via CARD-CARD-interactions (5, 6). ␬ IL-8 production. RIP2 is critical for NF- B activation induced by NOD1 and NOD2 The observation that XIAP gene knock-out impairs NOD- (11), although the molecular details of how the NOD/RIP2 com- signaling was further confirmed by quantitative RT-PCR analysis of ␬ plex stimulates NF- B activation are only partly understood. the NF-␬B target genes I␬B␣ and IL-8, detecting decreased levels RIP2 not only binds to NOD1 and NOD2 via CARD-CARD of I␬B␣ and IL-8 mRNAs in XIAP-deficient HCT116 cells com- interactions, but it also reportedly associates with other signaling pared with wild-type HCT116 cells following stimulation with MDP proteins independently of the CARD, including members of the or DAP (Fig. 1C). In contrast, TNF-␣ induced expression of these TNFR-associated factor (TRAF) family and members of the in- NF-␬B target genes comparably in XIAPϩ/ϩ and XIAPϪ/Ϫ cells. hibitor of apoptosis protein (IAP) family, cIAP-1 and cIAP-2 (12, Similar observations were made using a NF-␬B reporter gene to 13). IAP-family proteins play prominent roles in regulating pro- monitor responses to NOD ligands. In XIAPϩ/ϩ HCT116 cells, grammed cell death by virtue of their ability to bind caspases (14–17), intracellular cysteine proteases responsible for apoptosis. A common structural feature of the IAPs is the presence of one or Author contributions: A.K. and J.C.R. designed research; A.K., R.G.C., and J.B.G. performed more baculoviral IAP-repeat (BIR) domains, which serve as scaf- research; A.K., R.G.C., G.L.N., K.W., Z.H., W.T.K., and J.C.R. contributed new reagents/ folds for protein interactions (18). One of the most extensively analytic tools; A.K., R.G.C., J.B.G., and J.C.R. analyzed data; and A.K. and J.C.R. wrote the paper. investigated members of the IAP-family is X-linked IAP (XIAP). The authors declare no conflict of interest. XIAP contains three BIR domains (19), followed by a ubiquitin 1To whom correspondence should be addressed at: Burnham Institute for Medical Re- binding domain (UBA) (20) and a C-terminal RING that functions search, 10901 North Torrey Pines Road, La Jolla, CA 92037. E-mail: reedoffice@ as E3-Ligase promoting ubiquitination and subsequent proteaso- burnham.org. mal degradation of distinct target proteins (21). In additional to its This article contains supporting information online at www.pnas.org/cgi/content/full/ anti-apoptotic role as a caspase inhibitor, XIAP functions in certain 0907131106/DCSupplemental. www.pnas.org͞cgi͞doi͞10.1073͞pnas.0907131106 PNAS Early Edition ͉ 1of6 Downloaded by guest on September 29, 2021 Fig. 1. XIAP is required for induction of cytokine pro- duction by NOD ligands. (A and B) HCT 116 XIAP ϩ/ϩ (WT ϭ Wild-Type) and XIAP Ϫ/Ϫ cells (KO ϭ knock-out) (A) or DLD-1 XIAPϩ/ϩ or XIAP Ϫ/Ϫ cells (B) were stimu- lated with MDP (20 ␮g/mL), DAP (20 ␮g/mL), TNF-␣ (5 ng/mL), or left untreated for 24 h. Cell free supernatants were collected after centrifugation and analyzed for IL-8 secretion by ELISA. Data represent means Ϯ SD of three independent experiments (pg/mL). (C) Reduced expres- sion of NOD ligand-inducible genes in XIAP-deficient cells. HCT116 XIAPϪ/Ϫ (white bars) and XIAPϩ/ϩ (black bars) were stimulated for 1 h with various NF-␬B inducers: 20 ␮g/mL ␥Tri-DAP, 20 ␮g/mL MDP-LD, or 10 ng/mL TNF-␣. RNA was isolated and relative levels of I␬B␣ and IL-8 mRNAs were measured by Q-RT-PCR, normalized relative to 18S rRNA, expressed as relative levels compared with unstimulated cells (mean value ϭ 1), and presented as mean ϩ std dev of triplicate determinations performed in at least two independent experiments. (D) HCT116 XIAPϪ/Ϫ cells (KO) were transfected with FLAG-XIAP- encoding plasmid or empty FLAG-plasmid, then stimu- lated 24 h posttransfection with MDP (20 ␮g/mL), ␥Tri- DAP (20 ␮g/mL), TNF-␣ (5 ng/mL), or left untreated. As a control, HCT116 XIAPϩ/ϩ (WT) were similarly stimulated. NF-␬B reporter gene activity was measured after 24 h using the Dual Luciferase assay method. Normalized val- ues represented mean Ϯ SD (n ϭ 3). (Inset) Lysates from the cells were prepared, normalized for total protein content, and analyzed by immunoblotting using anti- XIAP antibody. Reprobing blot with anti-beta-Actin an- tibody confirmed equal loading. (E) XIAP deficiency se- lective impacts NOD-mediated NF-␬B activation. HEK293T cells containing a stably integrated NF-␬B- luciferase reporter gene were infected with XIAP shRNA (KD ϭ knock-down) (white bars) or scrambled control (CNTL) (black bar) lentiviruses. After 24 h, cells were stim- ulated with 10 ␮g/mL MDP-LD (MDP), 5 ␮g/mL ␥Tri-DAP (DAP), 0.2 ␮g/mL doxorubicin (DOX), 10 ng/mL PMA/ ionomycin (PMA), or 2 ng/mL TNF-␣. NF-␬B activity was measured 24 h later by luciferase activity, and data were expressed as fold-induction relative to control unstimu- lated values for each cell line (mean value ϭ 1) and represent mean Ϯ std dev of triplicates performed in at least two independent experiments.
Recommended publications
  • XIAP's Profile in Human Cancer
    biomolecules Review XIAP’s Profile in Human Cancer Huailu Tu and Max Costa * Department of Environmental Medicine, Grossman School of Medicine, New York University, New York, NY 10010, USA; [email protected] * Correspondence: [email protected] Received: 16 September 2020; Accepted: 25 October 2020; Published: 29 October 2020 Abstract: XIAP, the X-linked inhibitor of apoptosis protein, regulates cell death signaling pathways through binding and inhibiting caspases. Mounting experimental research associated with XIAP has shown it to be a master regulator of cell death not only in apoptosis, but also in autophagy and necroptosis. As a vital decider on cell survival, XIAP is involved in the regulation of cancer initiation, promotion and progression. XIAP up-regulation occurs in many human diseases, resulting in a series of undesired effects such as raising the cellular tolerance to genetic lesions, inflammation and cytotoxicity. Hence, anti-tumor drugs targeting XIAP have become an important focus for cancer therapy research. RNA–XIAP interaction is a focus, which has enriched the general profile of XIAP regulation in human cancer. In this review, the basic functions of XIAP, its regulatory role in cancer, anti-XIAP drugs and recent findings about RNA–XIAP interactions are discussed. Keywords: XIAP; apoptosis; cancer; therapeutics; non-coding RNA 1. Introduction X-linked inhibitor of apoptosis protein (XIAP), also known as inhibitor of apoptosis protein 3 (IAP3), baculoviral IAP repeat-containing protein 4 (BIRC4), and human IAPs like protein (hILP), belongs to IAP family which was discovered in insect baculovirus [1]. Eight different IAPs have been isolated from human tissues: NAIP (BIRC1), BIRC2 (cIAP1), BIRC3 (cIAP2), XIAP (BIRC4), BIRC5 (survivin), BIRC6 (apollon), BIRC7 (livin) and BIRC8 [2].
    [Show full text]
  • TAB1 Antibody Cat
    TAB1 Antibody Cat. No.: 3387 Western blot analysis of TAB1 in 3T3 cell lysate with TAB1 antibody at (A) 0.5, (B) 1, and (C) 2 μg/mL. Immunocytochemistry of TAB1 in K562 cells with TAB1 Immunofluorescence of TAB1 in 3T3 cells with TAB1 antibody at 1 μg/mL. antibody at 2 μg/mL. Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human, Mouse TAB1 antibody was raised against a synthetic peptide corresponding to 13 amino acids in the center of human TAB1. IMMUNOGEN: The immunogen is located within amino acids 220 - 270 of TAB1. TESTED APPLICATIONS: ELISA, ICC, IF, WB September 25, 2021 1 https://www.prosci-inc.com/tab1-antibody-3387.html TAB1 antibody can be used for the detection of TAB1 by Western blot at 0.5 to 2 μg/mL. Antibody can also be used for immunocytochemistry starting at 1 μg/mL. For immunofluorescence start at 2 μg/mL. APPLICATIONS: Antibody validated: Western Blot in mouse samples; Immunocytochemistry in human samples and Immunofluorescence in mouse samples. All other applications and species not yet tested. POSITIVE CONTROL: 1) Cat. No. 1212 - 3T3 Cell Lysate 2) Cat. No. 1204 - K562 Cell Lysate 3) Cat. No. 17-004 - K-562 Cell Slide 4) Cat. No. 17-201 - 3T3/BALB Cell Slide Properties PURIFICATION: TAB1 Antibody is affinity chromatography purified via peptide column. CLONALITY: Polyclonal ISOTYPE: IgG CONJUGATE: Unconjugated PHYSICAL STATE: Liquid BUFFER: TAB1 Antibody is supplied in PBS containing 0.02% sodium azide. CONCENTRATION: 1 mg/mL TAB1 antibody can be stored at 4˚C for three months and -20˚C, stable for up to one STORAGE CONDITIONS: year.
    [Show full text]
  • Ncounter® Mouse Autoimmune Profiling Panel - Gene and Probe Details
    nCounter® Mouse AutoImmune Profiling Panel - Gene and Probe Details Official Symbol Accession Alias / Previous Symbol Official Full Name Other targets or Isoform Information AW208573,CD143,expressed sequence AW208573,MGD-MRK- Ace NM_009598.1 1032,MGI:2144508 angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 2610036I19Rik,2610510L13Rik,Acinus,apoptotic chromatin condensation inducer in the nucleus,C79325,expressed sequence C79325,MGI:1913562,MGI:1919776,MGI:2145862,mKIAA0670,RIKEN cDNA Acin1 NM_001085472.2 2610036I19 gene,RIKEN cDNA 2610510L13 gene apoptotic chromatin condensation inducer 1 Acp5 NM_001102405.1 MGD-MRK-1052,TRACP,TRAP acid phosphatase 5, tartrate resistant 2310066K23Rik,AA960180,AI851923,Arp1b,expressed sequence AA960180,expressed sequence AI851923,MGI:2138136,MGI:2138359,RIKEN Actr1b NM_146107.2 cDNA 2310066K23 gene ARP1 actin-related protein 1B, centractin beta Adam17 NM_001277266.1 CD156b,Tace,tumor necrosis factor-alpha converting enzyme a disintegrin and metallopeptidase domain 17 ADAR1,Adar1p110,Adar1p150,AV242451,expressed sequence Adar NM_001038587.3 AV242451,MGI:2139942,mZaADAR adenosine deaminase, RNA-specific Adora2a NM_009630.2 A2AAR,A2aR,A2a, Rs,AA2AR,MGD-MRK-16163 adenosine A2a receptor Ager NM_007425.2 RAGE advanced glycosylation end product-specific receptor AI265500,angiotensin precursor,Aogen,expressed sequence AI265500,MGD- Agt NM_007428.3 MRK-1192,MGI:2142488,Serpina8 angiotensinogen (serpin peptidase inhibitor, clade A, member 8) Ah,Ahh,Ahre,aromatic hydrocarbon responsiveness,aryl hydrocarbon
    [Show full text]
  • "Description"" ""Generatio"
    TABLE S4 "ID ""Description"" ""GeneRatio"" ""BgRatio"" ""pvalue"" ""p.adjust"" ""qvalue"" ""geneID"" ""Count""" "GO:0003712 ""GO:0003712"" ""transcription coregulator activity"" ""84/1859"" ""454/22744"" 9.49597175224444e-13 9.80933882006851e-10 8.20651874588704e-10 ""Ncoa2/Zfp451/Dhx9/Hnrnpu/Cited2/Ncoa7/Ccar1/ Sirt1/Arid5b/Sirt6/Med1/Rara/Atxn7l3/Ddx5/Wbp2/Hdac9/Zmynd11/Cdyl/ Mier3/Sfmbt1/Gata4/Med4/Basp1/Zfpm2/Zhx2/Ddx17/Mkl2/Hes1/Nrip1/Usp16/ Elob/Rrp1b/Rxrb/Kat2b/Mta3/Hsbp1l1/Tle4/Sfr1/Eid1/Cops2/Sox12/Raly/ Ncoa6/Rbm39/Lpin3/Skil/Jade1/Maml3/Supt20/Med12l/Hdgf/Glmp/Nfib/Jun/ Pex14/Rere/Psmd9/Ncor2/Trim24/Ruvbl1/Rybp/Bhlhe40/Atf7ip/Ube3a/Mef2a/ Nrg1/Rbpms/Cnot7/Sin3b/Pou4f2/Pkn1/Cdyl2/Taf5l/Irf2bp2/Birc2/Yap1/ Skor1/Tfdp2/Rad54l2/Ctnnb1/Limd1/Med14/Rap2c/Tbl1x"" 84" "GO:0003779 ""GO:0003779"" ""actin binding"" ""65/1859"" ""414/22744"" 2.57546466939442e-07 8.86818334494813e-05 7.41914559148359e-05 ""Actr3/Cxcr4/Hnrnpu/Enah/Utrn/Epb41l2/Marcks/Ctnna3/Eef2/Pawr/ Ccdc88a/Anxa6/Gas7/Lasp1/Tns4/Syne2/Sipa1l1/Syne3/Phactr1/Enc1/Pxk/ Vcl/Ang/Myo10/Mtss1/Triobp/Mkl2/Afdn/Daam2/Svil/Ctnna1/Synpo/Myo5b/ Nrap/Ablim1/Shtn1/Fmnl2/Itprid2/Ino80/Pfn2/Myoz2/Pdlim5/Cap1/Macf1/ Epb41/Wasf2/Myom3/Ywhah/Coro1c/Ssh1/Hip1/Ppp1r9a/Wasl/Ctnna2/Mical3/ Eps8/Tlnrd1/Myom2/Klhl2/Sntb2/Spire2/Coro2b/Clasp2/Hdac6/Diaph2"" 65" "GO:0046332 ""GO:0046332"" ""SMAD binding"" ""22/1859"" ""84/22744"" 6.87941766027971e-07 0.000177660961076723 0.000148631628923412 ""Bmpr2/Cited2/Usp15/Ddx5/Axin2/Ppm1a/Yy1/Gata4/Tgif1/Ldlrad4/Smad7/ Acvr2a/Pmepa1/Skil/Trim33/Jun/Mef2a/Ipo7/Skor1/Rnf111/Tcf12/Ctnnb1""
    [Show full text]
  • TAB2 Antibody Catalog # ASC10267
    10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 TAB2 Antibody Catalog # ASC10267 Specification TAB2 Antibody - Product Information Application IHC Primary Accession Q9NYJ8 Other Accession NP_055908, 14149669 Reactivity Human Host Rabbit Clonality Polyclonal Isotype IgG Application Notes TAB2 antibody can be used for detection of TAB2 by immunohistoc Immunohistochemistry of TAB2 in human hemistry at 5 brain tissue with TAB2 antibody at 5 µg/mL. µg/mL. TAB2 Antibody - Background TAB2 Antibody - Additional Information TAB2 Antibody: TAB2 is an activator of Gene ID 23118 MAP3K7/TAK1, which is required for for the IL-1 Other Names induced activation NF-kappaB and MAPK8/JNK. TAB2 Antibody: CHTD2, MAP3K7IP2, This protein forms a kinase complex with KIAA0733, TGF-beta-activated kinase 1 and TRAF6, MAP3K7 and TAB1, thus serves as an MAP3K7-binding protein 2, adaptor linking MAP3K7 and TRAF6. This Mitogen-activated protein kinase kinase protein, TAB1, and MAP3K7 also participate in kinase 7-interacting protein 2, TAB-2, the signal transduction induced by TGF-beta activated kinase 1/MAP3K7 TNFSF11/RANKL through the activation of the binding protein 2 receptor activator of NF-kappaB (TNFRSF11A/RANK), which may regulate the Target/Specificity development and function of osteoclasts. TAB2; TAB2 antibody is human specific. Recent experiments have shown that TAB2 and TAB2 antibody is predicted not to cross-react with other TAB proteins. the related protein TAB3 constitutitvely interact with the autophagy mediator Beclin-1; Reconstitution & Storage upon induction of autophagy, these proteins TAB2 antibody can be stored at 4℃ for dissociate from Beclin-1 and bind TAK1.
    [Show full text]
  • Piperidylmethyloxychalcone Improves Immune-Mediated Acute Liver Failure
    OPEN Experimental & Molecular Medicine (2017) 49, e392; doi:10.1038/emm.2017.156 Official journal of the Korean Society for Biochemistry and Molecular Biology www.nature.com/emm ORIGINAL ARTICLE Piperidylmethyloxychalcone improves immune- mediated acute liver failure via inhibiting TAK1 activity Sun Hong Park1, Jeong-Ah Kwak1, Sang-Hun Jung2, Byeongwoo Ahn3, Won-Jea Cho4, Cheong-Yong Yun1, Chang Seon Na1, Bang Yeon Hwang1, Jin Tae Hong1, Sang-Bae Han1 and Youngsoo Kim1 Mice deficient in the toll-like receptor (TLR) or the myeloid differentiation factor 88 (MyD88) are resistant to acute liver failure (ALF) with sudden death of hepatocytes. Chalcone derivatives from medicinal plants protect from hepatic damages including ALF, but their mechanisms remain to be clarified. Here, we focused on molecular basis of piperidylmethyloxychalcone (PMOC) in the treatment of TLR/MyD88-associated ALF. C57BL/6J mice were sensitized with D-galactosamine (GalN) and challenged with Escherichia coli lipopolysaccharide (LPS, TLR4 agonist) or oligodeoxynucleotide containing unmethylated CpG motif (CpG ODN, TLR9 agonist) for induction of ALF. Post treatment with PMOC sequentially ameliorated hepatic inflammation, apoptosis of hepatocytes, severe liver injury and shock-mediated death in ALF-induced mice. As a mechanism, PMOC inhibited the catalytic activity of TGF-β-activated kinase 1 (TAK1) in a competitive manner with respect to ATP, displaced fluorescent ATP probe from the complex with TAK1, and docked at the ATP-binding active site on the crystal structure of TAK1. Moreover, PMOC inhibited TAK1 auto-phosphorylation, which is an axis in the activating pathways of nuclear factor-κB (NF-κB) or activating protein 1 (AP1), in the liver with ALF in vivo or in primary liver cells stimulated with TLR agonists in vitro.
    [Show full text]
  • TRAF6, a Molecular Bridge Spanning Adaptive Immunity, Innate Immunity and Osteoimmunology Hao Wu1* and Joseph R
    Review articles TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology Hao Wu1* and Joseph R. Arron2 Summary receptor/Toll-like receptor (IL-1R/TLR) superfamily. Gene Tumor necrosis factor (TNF) receptor associated factor targeting experiments have identified several indispen- 6 (TRAF6) is a crucial signaling molecule regulating a sable physiological functions of TRAF6, and structural diverse array of physiological processes, including and biochemical studies have revealed the potential adaptive immunity, innate immunity, bone metabolism mechanisms of its action. By virtue of its many signaling and the development of several tissues including lymph roles, TRAF6 represents an important target in the regu- nodes, mammary glands, skin and the central nervous lation of many disease processes, including immunity, system. It is a member of a group of six closely related inflammation and osteoporosis. BioEssays 25:1096– TRAF proteins, which serve as adapter molecules, coupl- 1105, 2003. ß 2003 Wiley Periodicals, Inc. ing the TNF receptor (TNFR) superfamily to intracellular signaling events. Among the TRAF proteins, TRAF6 is unique in that, in addition to mediating TNFR family Introduction signaling, it is also essential for signaling downstream of The tumor necrosis factor (TNF) receptor associated factors an unrelated family of receptors, the interleukin-1 (IL-1) (TRAFs) were first identified as two intracellular proteins, TRAF1 and TRAF2, associated with TNF-R2,(1) a member of 1Department of Biochemistry, Weill Medical College of Cornell the TNF receptor (TNFR) superfamily. There are currently six University, New York. mammalian TRAFs (TRAF1-6), which have emerged as 2Tri-Institutional MD-PhD Program, Weill Medical College of Cornell important proximal signal transducers for the TNFR super- University, New York.
    [Show full text]
  • TAB1 Rabbit Pab
    Leader in Biomolecular Solutions for Life Science TAB1 Rabbit pAb Catalog No.: A5749 Basic Information Background Catalog No. The protein encoded by this gene was identified as a regulator of the MAP kinase kinase A5749 kinase MAP3K7/TAK1, which is known to mediate various intracellular signaling pathways, such as those induced by TGF beta, interleukin 1, and WNT-1. This protein Observed MW interacts and thus activates TAK1 kinase. It has been shown that the C-terminal portion 70kDa of this protein is sufficient for binding and activation of TAK1, while a portion of the N- terminus acts as a dominant-negative inhibitor of TGF beta, suggesting that this protein Calculated MW may function as a mediator between TGF beta receptors and TAK1. This protein can also 49kDa/54kDa interact with and activate the mitogen-activated protein kinase 14 (MAPK14/p38alpha), and thus represents an alternative activation pathway, in addition to the MAPKK Category pathways, which contributes to the biological responses of MAPK14 to various stimuli. Alternatively spliced transcript variants encoding distinct isoforms have been reported. Primary antibody Applications WB, IF, IP Cross-Reactivity Human, Mouse Recommended Dilutions Immunogen Information WB 1:500 - 1:2000 Gene ID Swiss Prot 10454 Q15750 IF 1:10 - 1:100 Immunogen 1:50 - 1:200 IP Recombinant fusion protein containing a sequence corresponding to amino acids 205-504 of human TAB1 (NP_006107.1). Synonyms TAB1;3'-Tab1;MAP3K7IP1 Contact Product Information www.abclonal.com Source Isotype Purification Rabbit IgG Affinity purification Storage Store at -20℃. Avoid freeze / thaw cycles. Buffer: PBS with 0.02% sodium azide,50% glycerol,pH7.3.
    [Show full text]
  • Datasheet: VMA00296 Product Details
    Datasheet: VMA00296 Description: MOUSE ANTI TAB2 Specificity: TAB2 Format: Purified Product Type: PrecisionAb™ Monoclonal Isotype: IgG1 Quantity: 100 µl Product Details Applications This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit www.bio-rad-antibodies.com/protocols. Yes No Not Determined Suggested Dilution Western Blotting 1/1000 PrecisionAb antibodies have been extensively validated for the western blot application. The antibody has been validated at the suggested dilution. Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Further optimization may be required dependant on sample type. Target Species Human Product Form Purified IgG - liquid Preparation Mouse monoclonal antibody purified by affinity chromatography from ascites Buffer Solution Phosphate buffered saline Preservative 0.09% Sodium Azide (NaN ) Stabilisers 3 Immunogen Purified recombinant fragment of human TAB2 expressed in E. coli External Database Links UniProt: Q9NYJ8 Related reagents Entrez Gene: 23118 TAB2 Related reagents Synonyms KIAA0733, MAP3K7IP2 Specificity Mouse anti Human TAB2 antibody recognizes the TGF-beta-activated kinase 1 and MAP3K7- binding protein 2, also known as TAK1-binding protein 2, mitogen-activated protein kinase and kinase kinase 7-interacting protein 2. Page 1 of 2 Encoded by the TAB2 gene, TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 is an activator of MAP3K7/TAK1, which is required for for the IL-1 induced activation of nuclear factor kappaB and MAPK8/JNK.
    [Show full text]
  • Ncounter® Human Autoimmune Profiling Panel
    nCounter® Human AutoImmune Profiling Panel - Gene and Probe Details Official Symbol Accession Alias / Previous Symbol Official Full Name Other targets or Isoform Information ACE NM_000789.2 DCP1;angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 angiotensin I converting enzyme ACIN1 NM_001164815.1 ACINUS;apoptotic chromatin condensation inducer in the nucleus apoptotic chromatin condensation inducer 1 ACP5 NM_001611.3 acid phosphatase 5, tartrate resistant CTRN2;ARP1 (actin-related protein 1, yeast) homolog B (centractin beta),ARP1 actin-related ACTR1B NM_005735.3 protein 1 homolog B, centractin beta ARP1 actin related protein 1 homolog B ADAM17 NM_003183.4 TACE;tumor necrosis factor, alpha, converting enzyme ADAM metallopeptidase domain 17 ADAR NM_001111.3 IFI4,G1P1;interferon-induced protein 4 adenosine deaminase, RNA specific ADORA2A NM_000675.3 ADORA2 adenosine A2a receptor AGER NM_001136.3 advanced glycosylation end-product specific receptor AGT NM_000029.3 SERPINA8;serpin peptidase inhibitor, clade A, member 8 angiotensinogen AHR NM_001621.3 aryl hydrocarbon receptor AICDA NM_020661.2 activation-induced cytidine deaminase activation induced cytidine deaminase AIM2 NM_004833.1 absent in melanoma 2 APECED;autoimmune regulator (autoimmune polyendocrinopathy candidiasis ectodermal AIRE NM_000383.2 dystrophy) autoimmune regulator AKT1 NM_001014432.1 v-akt murine thymoma viral oncogene homolog 1 AKT serine/threonine kinase 1 AKT2 NM_001626.4 v-akt murine thymoma viral oncogene homolog 2 AKT serine/threonine kinase 2 AKT3 NM_005465.4
    [Show full text]
  • TAB2 Antibody Cat
    TAB2 Antibody Cat. No.: 3389 TAB2 Antibody Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human HOMOLOGY: Predicted species reactivity based on immunogen sequence: Rat: (86%), Mouse: (79%) TAB2 antibody was raised against a 14 amino acid synthetic peptide near the carboxy terminus of human TAB2. IMMUNOGEN: The immunogen is located within the last 50 amino acids of TAB2. TESTED APPLICATIONS: ELISA, IHC-P TAB2 antibody can be used for detection of TAB2 by immunohistochemistry at 5 μg/mL. APPLICATIONS: Antibody validated: Immunohistochemistry in human samples. All other applications and species not yet tested. TAB2 antibody is human specific. TAB2 antibody is predicted not to cross-react with other SPECIFICITY: TAB proteins. POSITIVE CONTROL: 1) Cat. No. 10-301 - Human Brain Tissue Slide Properties PURIFICATION: TAB2 Antibody is affinity chromatography purified via peptide column. CLONALITY: Polyclonal September 23, 2021 1 https://www.prosci-inc.com/tab2-antibody-3389.html ISOTYPE: IgG CONJUGATE: Unconjugated PHYSICAL STATE: Liquid BUFFER: TAB2 Antibody is supplied in PBS containing 0.02% sodium azide. CONCENTRATION: 1 mg/mL TAB2 antibody can be stored at 4˚C for three months and -20˚C, stable for up to one STORAGE CONDITIONS: year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. Additional Info OFFICIAL SYMBOL: TAB2 TAB2 Antibody: CHTD2, MAP3K7IP2, KIAA0733, TGF-beta-activated kinase 1 and MAP3K7- ALTERNATE NAMES: binding protein 2, Mitogen-activated protein kinase kinase kinase 7-interacting protein 2, TAB-2 ACCESSION NO.: NP_055908 PROTEIN GI NO.: 14149669 GENE ID: 23118 USER NOTE: Optimal dilutions for each application to be determined by the researcher.
    [Show full text]
  • Recognition of a Glycosylation Substrate by the O-Glcnac Transferase TPR Repeats
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Serveur académique lausannois Recognition of a glycosylation substrate by the O-GlcNAc transferase TPR repeats rsob.royalsocietypublishing.org Karim Rafie1,†, Olawale Raimi1,†, Andrew T. Ferenbach1, Vladimir S. Borodkin1, Vaibhav Kapuria2 and Daan M. F. van Aalten1 1Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK 2Center for Integrative Genomics, University of Lausanne 1015, Switzerland Research DMFvA, 0000-0002-1499-6908 Cite this article: Rafie K, Raimi O, Ferenbach O-linked N-acetylglucosamine (O-GlcNAc) is an essential and dynamic post- AT, Borodkin VS, Kapuria V, van Aalten DMF. translational modification found on hundreds of nucleocytoplasmic proteins 2017 Recognition of a glycosylation substrate in metazoa. Although a single enzyme, O-GlcNAc transferase (OGT), gener- by the O-GlcNAc transferase TPR repeats. Open ates the entire cytosolic O-GlcNAc proteome, it is not understood how it recognizes its protein substrates, targeting only a fraction of serines/ Biol. 7: 170078. threonines in the metazoan proteome for glycosylation. We describe a http://dx.doi.org/10.1098/rsob.170078 trapped complex of human OGT with the C-terminal domain of TAB1, a key innate immunity-signalling O-GlcNAc protein, revealing extensive interactions with the tetratricopeptide repeats of OGT. Confirmed by muta- genesis, this interaction suggests that glycosylation substrate specificity is Received: 30 March 2017 achieved by recognition of a degenerate sequon in the active site combined Accepted: 2 June 2017 with an extended conformation C-terminal of the O-GlcNAc target site.
    [Show full text]